Skip to main content
. 2019 Dec 10;19(2):1187–1194. doi: 10.3892/ol.2019.11201

Table I.

Comparison of the general data of patients in the two groups [n (%), mean ± SD].

Category n Propofol group (n=60) Sevoflurane group (n=50) χ2/t-test P-value
Sex 0.469 0.524
  Male 70 40 (66.67) 30 (60.00)
  Female 40 20 (33.33) 20 (40.00)
Age (years) 0.764 0.382
  ≤60 60 35 (58.33) 25 (50.00)
  >60 50 25 (41.67) 25 (50.00)
BMI (kg/m2) 110 22.50±4.50 22.40±4.60 0.115 0.909
Smoking history 0.177 0.860
  No 45 25 (41.67) 20 (40.00)
  Yes 65 35 (58.33) 30 (60.00)
Drinking history 2.700 0.100
  No 51 23 (38.33) 28 (56.00)
  Yes 59 37 (61.67) 22 (44.00)
Hypertension 0.046 0.831
  No 43 24 (40.00) 19 (38.00)
  Yes 67 36 (60.00) 31 (62.00)
Marital status 2.829 0.093
  Unmarried 35 15 (25.00) 20 (40.00)
  Married 75 45 (75.00) 30 (60.00)
TNM stage 0.031 0.860
  I/II 65 35 (58.33) 30 (60.00)
  III/IV 45 25 (41.67) 20 (40.00)
Pathological differentiation degree 1.604 0.205
  Middle/high differentiation 70 35 (58.33) 35 (70.00)
  Low differentiation 40 25 (41.67) 15 (30.00)
ASA grade 1.243 0.265
  Grade I 53 26 (43.33) 27 (54.00)
  Grade II 57 34 (56.67) 23 (46.00)

BMI, body mass index; ASA, American Society of Anesthesiologists.